Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02402712
Brief Title: Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer

First Submitted : March 23, 2015
First Submitted that Met QC Criteria : March 25, 2015
First Posted : March 30, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : April 1, 2019
Last Update Posted : April 2, 2019